Hardy Zhou

Cooley represented Andreessen Horowitz (a16z), a Silicon Valley-based venture capital firm that backs bold entrepreneurs building the future through technology, on the $500 million closing of its Biotech Ecosystem Venture Fund – a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health.

Cooley advised Brigit, a financial health technology company, on its definitive agreement to be acquired by Upbound Group (Nasdaq: UPBD), a technology- and data-driven leader in accessible and inclusive financial products that address the evolving needs and aspirations of underserved consumers, for total consideration of up to $460 million.

Cooley advised Frame AI, an artificial intelligence-powered platform, on its sale to HubSpot, the leading customer platform for scaling businesses.

Cooley advised the underwriters of Septerna, a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery, on its upsized $331.2 million initial public offering.